Lopinavir and ritonavir

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 31722-603
  • Package NDC 31722-603-12
  • Package NDC 31722-603-60
  • Application number ANDA091677
  • SPL ID c3de2763-2221-d566-e053-2995a90ab15f
  • SPL set ID 4e5005b8-f00c-4671-be09-bb927190760f
  • UNII O3J8G9O825
  • UNII 2494G1JF75
  • RxCUI 597730
  • RxCUI 746645

What the source publishes

Labeler
Camber Pharmaceuticals, Inc.
Active ingredients
Lopinavir and ritonavir
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:31722-603_c3de2763-2221-d566-e053-2995a90ab15f
{
  "name": "Lopinavir and ritonavir",
  "splId": "c3de2763-2221-d566-e053-2995a90ab15f",
  "labels": [
    {
      "setId": "4e5005b8-f00c-4671-be09-bb927190760f",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e5005b8-f00c-4671-be09-bb927190760f",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4e5005b8-f00c-4671-be09-bb927190760f"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Camber Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "120 TABLET, FILM COATED in 1 BOTTLE (31722-603-12)",
      "package_ndc": "31722-603-12",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210607"
    },
    {
      "sample": false,
      "description": "60 TABLET, FILM COATED in 1 BOTTLE (31722-603-60)",
      "package_ndc": "31722-603-60",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210607"
    }
  ],
  "productId": "31722-603_c3de2763-2221-d566-e053-2995a90ab15f",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "31722-603",
  "deaSchedule": null,
  "genericName": "Lopinavir and ritonavir",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LOPINAVIR",
      "strength": "100 mg/1"
    },
    {
      "name": "RITONAVIR",
      "strength": "25 mg/1"
    }
  ],
  "applicationNumber": "ANDA091677",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20210607",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000000246",
      "N0000191001",
      "N0000175889",
      "N0000190114",
      "N0000182137",
      "N0000185607",
      "N0000190118",
      "N0000185503",
      "N0000190113",
      "N0000182141",
      "N0000191266",
      "N0000185507",
      "N0000187064",
      "N0000190117",
      "N0000190107"
    ],
    "upc": [
      "0331722603607",
      "0331722556125"
    ],
    "unii": [
      "O3J8G9O825",
      "2494G1JF75"
    ],
    "rxcui": [
      "597730",
      "746645"
    ],
    "spl_set_id": [
      "4e5005b8-f00c-4671-be09-bb927190760f"
    ],
    "pharm_class_epc": [
      "Cytochrome P450 3A Inhibitor [EPC]",
      "Protease Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "HIV Protease Inhibitors [MoA]",
      "Cytochrome P450 3A Inhibitors [MoA]",
      "Cytochrome P450 2D6 Inhibitors [MoA]",
      "Cytochrome P450 2C19 Inducers [MoA]",
      "Cytochrome P450 3A Inducers [MoA]",
      "P-Glycoprotein Inhibitors [MoA]",
      "Breast Cancer Resistance Protein Inhibitors [MoA]",
      "Cytochrome P450 3A4 Inhibitors [MoA]",
      "Cytochrome P450 1A2 Inducers [MoA]",
      "Cytochrome P450 2C9 Inducers [MoA]",
      "Cytochrome P450 2B6 Inducers [MoA]",
      "UDP Glucuronosyltransferases Inducers [MoA]",
      "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Camber Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:31722-603_c3de2763-2221-d566-e053-2995a90ab15f"